Christopher Bowden insider trades
Open-market stock purchases and sales by Christopher Bowden, Director at Bicara Therapeutics Inc, from SEC Form 4 filings since May 31, 2014.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 9, 2026 | BCAX Bicara Therapeutics Inc | Bought (not open market) | — |
Companies traded
- BCAX Bicara Therapeutics Inc: other filings, last Jun 9, 2026
- TCRT Alaunos Therapeutics, Inc: other filings, last Jun 22, 2022
- AGIO Agios Pharmaceuticals, Inc: 38 sales, last Jun 18, 2021
- ZIOP Ziopharm Oncology Inc: other filings, last Mar 4, 2021
- MGEN Miragen Therapeutics, Inc: other filings, last May 21, 2020